Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the devastating global COVID-19 pandemic announced by WHO in March 2020. Through …

The global challenges posed by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) pandemic have underscored the critical importance of innovative and …

The SARS-CoV-2 virus has been identified as the infectious agent that led to the COVID-19
pandemic, which the world has seen very recently. Researchers have linked the SARS-CoV …

Global health and economy are deeply influenced by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and its newly emerging variants. Nanobodies with nanometer …

Viral nanoparticles (VNPs) are self-assembled nanometric complexes whose size and
shape are similar to those of the virus from which they are derived. VNPs are arousing great …

The coronavirus (CoV) disease 2019 (COVID-19) is expected to become endemic in the
coming years, meaning that the worldwide society shall be prepared to routinely manage the …

Antimicrobial resistance (AMR) poses a significant threat to human health. Although
vaccines have been developed to combat AMR, it has proven challenging to associate …

The membrane (M) glycoprotein of SARS-CoV-2 is one of the key viral proteins regulating
virion assembly and morphogenesis. Immunologically, the M protein is a major source of …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of a
potentially severe respiratory disease, the coronavirus disease 2019 (COVID-19), an …

The high mutation rate of SARS-CoV-2 genomic RNA has made COVID-19 more difficult to
eradicate using currently available interventions. Hence, newer pharmaceutical strategies …